The MR imaging diagnosis of liver diseases using gadoxetic acid: Emphasis on hepatobiliary phase.
10.3350/cmh.2013.19.4.360
- Author:
Woo Kyoung JEONG
1
;
Young Kon KIM
;
Kyoung Doo SONG
;
Dongil CHOI
;
Hyo Keun LIM
Author Information
1. Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. jeongwk@gmail.com
- Publication Type:Review
- Keywords:
Magnetic resonance imaging;
Gadoxetic acid;
Focal hepatic lesion;
Hepatocellular carcinoma;
Metastasis;
Focal nodular hyperplasia
- MeSH:
Carcinoma, Hepatocellular/radiography;
Cholangiocarcinoma/radiography;
Contrast Media/chemistry/*diagnostic use;
Hemangioma/radiography;
Humans;
Liver Diseases/*radiography;
Liver Neoplasms/radiography;
Magnetic Resonance Imaging;
Meglumine/*analogs & derivatives/chemistry/diagnostic use;
Organometallic Compounds/chemistry/*diagnostic use
- From:Clinical and Molecular Hepatology
2013;19(4):360-366
- CountryRepublic of Korea
- Language:English
-
Abstract:
Hepatocyte specific contrast agents including gadoxetic acid and gadobenate dimeglumine are very useful to diagnose various benign and malignant focal hepatic lesions and even helpful to estimate hepatic functional reservoir. The far delayed phase image referred to as the hepatobiliary phase makes the sensitivity of detection for malignant focal hepatic lesions increased, but specificity of malignant diseases, including hepatocellular carcinoma, metastasis and cholangiocarcinoma, characterization remained to be undetermined.
